At a glance
ClinicalIndex Comparison RecordN/ACompleted· 450 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation of the SLEDAI-P/LUPIN Self-questionnaire Completed by the Patient to Measure the Activity of the Systemic Lupus
Association Francaise du Lupus et Autres Maladies Auto-immunes (AFL+)·observational·Posted Mar 10, 2023·Updated Jul 31, 2024
In Brief
An observational study for Lupus Erythematosus, Systemic. Completed, enrolled 450 participants across 31 sites in 3 countries.
Detailed Summary
Validation of a self-questionnaire (SLEDAI-P/LUPIN) completed by the patient to measure the activity of the systemic lupus, in order to improve the patient's empowerment.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLupus Erythematosus, Systemic
CountriesFrance, Guadeloupe, Martinique
CollaboratorsHometrix Health SAS
Timeline
N/ACompletedFinished
202420252026
Enrollment StartFeb 2023
First PostedMar 2023
Primary CompletionJun 2024
Study CompletionJun 2024
TodayJul 2026
First PostedMar 10, 2023
Enrollment StartFeb 9, 2023
Primary CompletionJun 1, 2024
Study CompletionJun 15, 2024
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 3.3 years ago